Get the Stockscreener App
31.72
0.27%
-0.04
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Axogen Inc stock is traded at $31.72, with a volume of 17,029.
It is down -0.27% in the last 24 hours and down -4.94% over the past month.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
See More
Previous Close:
$31.76
Open:
$31.47
24h Volume:
17,029
Relative Volume:
0.02
Market Cap:
$1.47B
Revenue:
$203.27M
Net Income/Loss:
$-4.66M
P/E Ratio:
-317.20
EPS:
-0.1
Net Cash Flow:
$3.47M
1W Performance:
-3.23%
1M Performance:
-4.94%
6M Performance:
+189.79%
1Y Performance:
+117.54%
1-Day Range:
$31.47
$31.79
1-Week Range:
$30.32
$33.34
52-Week Range:
$9.215
$34.24
Axogen Inc Stock (AXGN) Company Profile
Name
Axogen Inc
Sector
Industry
Phone
(386) 462-6817
Address
13631 PROGRESS BLVD., ALACHUA, FL
Compare AXGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AXGN
Axogen Inc
|
31.79 | 1.46B | 203.27M | -4.66M | 3.47M | -0.10 |
|
ABT
Abbott Laboratories
|
128.41 | 219.88B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.54 | 141.54B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
355.37 | 133.39B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.75 | 124.82B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.69 | 48.84B | 5.88B | 1.34B | 799.60M | 2.3489 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-01-25 | Initiated | Mizuho | Outperform |
| Mar-17-25 | Initiated | Lake Street | Buy |
| Jul-01-24 | Initiated | Raymond James | Outperform |
| Nov-11-22 | Resumed | Jefferies | Buy |
| May-09-22 | Upgrade | Canaccord Genuity | Hold → Buy |
| Mar-11-22 | Resumed | Cantor Fitzgerald | Overweight |
| Oct-23-20 | Initiated | Guggenheim | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| May-07-20 | Downgrade | Canaccord Genuity | Buy → Hold |
| Apr-02-20 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-12-19 | Initiated | Canaccord Genuity | Buy |
| Mar-02-18 | Reiterated | Lake Street | Buy |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Overweight |
| Nov-30-17 | Initiated | Jefferies | Buy |
| Nov-21-17 | Reiterated | Lake Street | Buy |
| Jul-31-17 | Initiated | Leerink Partners | Outperform |
| Jun-30-17 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-06-17 | Initiated | ROTH Capital | Buy |
| Nov-22-16 | Upgrade | Lake Street | Hold → Buy |
| Nov-07-16 | Reiterated | Wedbush | Outperform |
| Nov-03-16 | Downgrade | Lake Street | Buy → Hold |
| Aug-04-16 | Reiterated | Wedbush | Outperform |
| May-14-14 | Initiated | Dawson James | Buy |
| Oct-31-13 | Reiterated | Ladenburg Thalmann | Buy |
View All
Axogen Inc Stock (AXGN) Latest News
Axogen, Inc. (NASDAQ:AXGN) Could Be Less Than A Year Away From Profitability - simplywall.st
Growth Value: Is Axogen Inc stock affected by interest rate hikesQuarterly Market Review & AI Enhanced Trading Signals - moha.gov.vn
AxoGen (NASDAQ:AXGN) Stock Price Down 6.1%Time to Sell? - MarketBeat
AxoGen, Inc. $AXGN Shares Bought by HighMark Wealth Management LLC - MarketBeat
AxoGen, Inc. (NASDAQ:AXGN) Short Interest Down 17.8% in December - MarketBeat
Discipline and Rules-Based Execution in AXGN Response - Stock Traders Daily
Will Axogen Inc stock maintain dividend yieldWeekly Trading Summary & Advanced Technical Signal Analysis - moha.gov.vn
Rice Hall James & Associates LLC Sells 45,709 Shares of AxoGen, Inc. $AXGN - MarketBeat
AxoGen (NASDAQ:AXGN) Shares Down 3%Here's What Happened - MarketBeat
Are Investors Undervaluing Axogen, Inc. (NASDAQ:AXGN) By 31%? - Yahoo Finance
Is Axogen Inc. stock affected by interest rate hikesWeekly Volume Report & Expert Curated Trade Setup Alerts - bolumsonucanavari.com
Assenagon Asset Management S.A. Grows Stake in AxoGen, Inc. $AXGN - MarketBeat
How interest rate cuts could boost Axogen Inc. stockTake Profit & AI Driven Stock Price Forecasts - Улправда
How Axogen Inc. stock benefits from global expansionMarket Sentiment Summary & Weekly Watchlist for Hot Stocks - Улправда
Axogen (FRA:LT3) EV-to-OCF : 227.22 (As of Dec. 19, 2025) - GuruFocus
Bull Run: Will Axogen Inc. stock outperform tech sector in 2025July 2025 Snapshot & Long-Term Capital Growth Ideas - Улправда
Will Axogen Inc. stock maintain dividend yieldMarket Movers & Fast Gaining Stock Reports - DonanımHaber
Why Axogen Inc. stock remains on buy listsInflation Watch & Stepwise Entry and Exit Trade Signals - DonanımHaber
Risk Analysis: How Axogen Inc. stock trades during market volatility2025 Market Outlook & Daily Growth Stock Tips - ulpravda.ru
Will Axogen Inc. stock benefit from commodity pricesJuly 2025 Setups & Community Verified Watchlist Alerts - Улправда
How Does Axogen Stock Compare With Peers? - Trefis
Lindsey Marie Hartley Sells 14,812 Shares of AxoGen (NASDAQ:AXGN) Stock - MarketBeat
Amy Mcbride Wendell Sells 43,684 Shares of AxoGen (NASDAQ:AXGN) Stock - MarketBeat
AxoGen (NASDAQ:AXGN) Director Sells $1,378,596.15 in Stock - MarketBeat
Axogen Executives Conduct Significant Stock Transactions - TradingView — Track All Markets
[Form 4] Axogen, Inc. Insider Trading Activity - Stock Titan
Axogen (NASDAQ: AXGN) director exercises options and sells 46,653 shares - Stock Titan
Axogen, Inc. (AXGN) CFO reports option exercise and stock sale in Form 4 - Stock Titan
AxoGen (NASDAQ:AXGN) Stock Price Up 5.4%What's Next? - MarketBeat
AxoGen, Inc. (NASDAQ:AXGN) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Axogen, Inc. to Participate in the J.P. Morgan 2026 Healthcare Conference - The Manila Times
AXGN stock rises pre-market after FDA approves nerve repair graft - MSN
Axogen (AXGN): Reassessing Valuation After FDA BLA Approval for AVANCE Nerve Allograft - Sahm
Dir Weiler Files To Sell 46,653 Of Axogen Inc [AXGN] - TradingView — Track All Markets
Squarepoint Ops LLC Purchases 348,950 Shares of AxoGen, Inc. $AXGN - MarketBeat
With Axogen Stock Surging, Have You Considered The Downside? - Trefis
Would You Still Hold Axogen Stock If It Fell Another 30%? - Trefis
Axogen (AXGN) price target increased by 18.26% to 34.58 - MSN
Should FDA Biologic Approval of AVANCE Nerve Scaffold Require Action From Axogen (AXGN) Investors? - simplywall.st
Is Axogen Stock Built to Withstand More Downside? - Trefis
Leerink Partners raises AxoGen stock price target to $40 on BLA approval - Investing.com Nigeria
Can Axogen Stock Recover If Markets Fall? - Trefis
Insider Sell: Marc Began Sells Shares of Axogen Inc (AXGN) - GuruFocus
Leerink Partners raises AxoGen stock price target to $40 on BLA approval By Investing.com - Investing.com South Africa
Trade Alert: President Of Axogen Michael Dale Has Sold Stock - simplywall.st
Armistice Capital LLC Boosts Holdings in AxoGen, Inc. $AXGN - MarketBeat
Michael Dale Sells 61,463 Shares of AxoGen (NASDAQ:AXGN) Stock - MarketBeat
Paul Thomas Sells 21,399 Shares of AxoGen (NASDAQ:AXGN) Stock - MarketBeat
Joseph Tyndall Sells 25,108 Shares of AxoGen (NASDAQ:AXGN) Stock - MarketBeat
AxoGen (NASDAQ:AXGN) CFO Sells $454,053.72 in Stock - MarketBeat
John Johnson Sells 21,686 Shares of AxoGen (NASDAQ:AXGN) Stock - MarketBeat
Axogen Inc Stock (AXGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
0.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):